AlphaCrest Capital Management’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-55,454
| Closed | -$599K | – | 54 |
|
|
2022
Q3 | $599K | Buy |
55,454
+34,176
| +161% | +$369K | 0.04% | 898 |
|
|
2022
Q2 | $243K | Sell |
21,278
-28,296
| -57% | -$323K | 0.01% | 1168 |
|
|
2022
Q1 | $452K | Buy |
49,574
+22,540
| +83% | +$206K | 0.03% | 942 |
|
|
2021
Q4 | $403K | Buy |
+27,034
| New | +$403K | 0.02% | 1170 |
|
|
2021
Q3 | – | Sell |
-81,305
| Closed | -$2.12M | – | 1230 |
|
|
2021
Q2 | $2.12M | Buy |
81,305
+65,005
| +399% | +$1.69M | 0.09% | 343 |
|
|
2021
Q1 | $575K | Buy |
16,300
+4,900
| +43% | +$173K | 0.03% | 740 |
|
|
2020
Q4 | $288K | Buy |
+11,400
| New | +$288K | 0.02% | 933 |
|